HomeACIU • NASDAQ
add
AC Immune SA
Previous close
$3.29
Day range
$3.21 - $3.40
Year range
$2.25 - $5.13
Market cap
334.42M USD
Avg Volume
119.49K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (CHF) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 25.48M | — |
Operating expense | 3.73M | 22.07% |
Net income | 5.50M | 136.34% |
Net profit margin | 21.59 | — |
Earnings per share | 0.05 | 127.78% |
EBITDA | 7.63M | 150.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 157.90M | 97.55% |
Total assets | 244.25M | 70.82% |
Total liabilities | 114.08M | 558.60% |
Total equity | 130.16M | — |
Shares outstanding | 99.84M | — |
Price to book | 2.53 | — |
Return on assets | 7.54% | — |
Return on capital | 13.98% | — |
Cash Flow
Net change in cash
| (CHF) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 5.50M | 136.34% |
Cash from operations | -14.14M | -6.34% |
Cash from investing | -2.09M | -144.22% |
Cash from financing | -173.00K | -138.62% |
Net change in cash | -19.15M | -136.97% |
Free cash flow | -18.45M | -112.87% |
About
Founded
2003
Website
Employees
147
